Sullivan TJ - Search Results

1

Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.

Chambers CA, Sullivan TJ, Allison JP. Chambers CA, et al. Among authors: sullivan tj. Immunity. 1997 Dec;7(6):885-95. doi: 10.1016/s1074-7613(00)80406-9. Immunity. 1997. PMID: 9430233

2

Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.

Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Hurwitz AA, et al. Among authors: sullivan tj. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3013-7. doi: 10.1073/pnas.042684699. Epub 2002 Feb 26. Proc Natl Acad Sci U S A. 2002. PMID: 11867713 Free PMC article.

3

CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.

Engelhardt JJ, Sullivan TJ, Allison JP. Engelhardt JJ, et al. Among authors: sullivan tj. J Immunol. 2006 Jul 15;177(2):1052-61. doi: 10.4049/jimmunol.177.2.1052. J Immunol. 2006. PMID: 16818761

4

Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.

Corse E, Gottschalk RA, Park JS, Sepulveda MA, Loke P, Sullivan TJ, Johnson LK, Allison JP. Corse E, et al. Among authors: sullivan tj. J Immunol. 2013 Jan 15;190(2):526-30. doi: 10.4049/jimmunol.1202621. Epub 2012 Dec 17. J Immunol. 2013. PMID: 23248264 Free PMC article.

5

Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.

Sullivan TJ, Letterio JJ, van Elsas A, Mamura M, van Amelsfort J, Sharpe S, Metzler B, Chambers CA, Allison JP. Sullivan TJ, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2587-92. doi: 10.1073/pnas.051632398. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226283 Free PMC article.

6

Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells.

Chambers CA, Sullivan TJ, Truong T, Allison JP. Chambers CA, et al. Among authors: sullivan tj. Eur J Immunol. 1998 Oct;28(10):3137-43. doi: 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X. Eur J Immunol. 1998. PMID: 9808182

7

Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.

Hurwitz AA, Sullivan TJ, Krummel MF, Sobel RA, Allison JP. Hurwitz AA, et al. Among authors: sullivan tj. J Neuroimmunol. 1997 Mar;73(1-2):57-62. doi: 10.1016/s0165-5728(96)00168-3. J Neuroimmunol. 1997. PMID: 9058759

8

Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo.

Krummel MF, Sullivan TJ, Allison JP. Krummel MF, et al. Among authors: sullivan tj. Int Immunol. 1996 Apr;8(4):519-23. doi: 10.1093/intimm/8.4.519. Int Immunol. 1996. PMID: 8671638

9

The role of CTLA-4 in the regulation and initiation of T-cell responses.

Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP. Chambers CA, et al. Among authors: sullivan tj. Immunol Rev. 1996 Oct;153:27-46. doi: 10.1111/j.1600-065x.1996.tb00919.x. Immunol Rev. 1996. PMID: 9010718 Review. No abstract available.

10

A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance?

Allison JP, Chambers C, Hurwitz A, Sullivan T, Boitel B, Fournier S, Brunner M, Krummel M. Allison JP, et al. Novartis Found Symp. 1998;215:92-8; discussion 98-102, 186-90. doi: 10.1002/9780470515525.ch7. Novartis Found Symp. 1998. PMID: 9760573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results